A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants

Clinical trial NCT02109042 · COMPLETED

Trial details

NCT number: NCT02109042
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2014-04-01
Primary completion: 2014-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.